Viewing Study NCT05969418


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2025-12-26 @ 3:54 AM
Study NCT ID: NCT05969418
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2023-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC
Sponsor: Federico II University
Organization:

Study Overview

Official Title: Deep Learning OCT and OCTA Quantification in Neovascular Age Related Macular Degeneration
Status: COMPLETED
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OCTA
Brief Summary: To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.
Detailed Description: Exudative neovascular macular degeneration is the primarily an age-related retinal condition The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features in order to choose the best therapy .

The study evaluates the changes in structural optical coherence tomography and optical coherence tomography angiography features in neovascular macular degeration patients undergoing ANTI-VEGF treatments using artificial intelligence.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: